Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Steadman Philippon Research Institute has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This activity is confined to a distinct examiner and a distinct art unit. The data indicates a narrow scope of current prosecution for the company's patent interests. This focus allows for a specialized response to the examiner's findings without the need to coordinate across multiple pending matters.
RICCI, CRAIG D is the busiest examiner for the portfolio, who is handling 1 pending office action. This examiner is responsible for the only pending matter identified in the company's profile. Prosecution efforts are currently centralized, requiring the company to address the specific feedback from this examiner. Success in this technology area is currently dependent on the dialogue with this individual in the specified art unit. By focusing on the 1 pending action and the distinct examiner involved, the company can efficiently manage its intellectual property assets in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18040959 | OPTIMIZED SURGERY PROTOCOL AND KITS | RICCI, CRAIG D | 31d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18040959 | OPTIMIZED SURGERY PROTOCOL AND KITS | RICCI, CRAIG D | 31d overdue |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18040959 | OPTIMIZED SURGERY PROTOCOL AND KITS | RICCI, CRAIG D | 1611 | §102§103§112 | Final Rejection | 31d overdue | Pending | Feb 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial